摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10Z-Hymenialdisine | 82005-12-7

中文名称
——
中文别名
——
英文名称
10Z-Hymenialdisine
英文别名
(4E)-4-(2-amino-5-oxo-1H-imidazol-4-ylidene)-2-bromo-1,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8-one
10Z-Hymenialdisine化学式
CAS
82005-12-7
化学式
C11H10BrN5O2
mdl
——
分子量
324.13
InChiKey
ATBAETXFFCOZOY-QPJJXVBHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    2.20±0.1 g/cm3(Predicted)
  • 溶解度:
    在 DMSO 中溶解度为 10 mM
  • 稳定性/保质期:

    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    19
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    112
  • 氢给体数:
    4
  • 氢受体数:
    2

SDS

SDS:dd164ea04f95ff33570ace3bfb1c0778
查看

文献信息

  • Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
    申请人:——
    公开号:US20040186159A1
    公开(公告)日:2004-09-23
    The use of inhibitors of GSK-3 useful for treating glaucoma is disclosed.
    抑制GSK-3用于治疗青光眼的方法被揭示。
  • METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION
    申请人:Frequency Therapeutics, Inc.
    公开号:US20200121681A1
    公开(公告)日:2020-04-23
    The present invention relates to compositions of minoxidil and Sonic Hedgehog (Shh) pathway activators and optionally, Wnt agonists and methods of using them to induce self-renewal of hair follicle stem cells, including inducing the hair follicle stem cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair follicle epithelial cells.
    本发明涉及米诺地尔和Sonic Hedgehog (Shh)途径激活剂以及可选的Wnt激动剂的组合物,以及使用它们诱导毛囊干细胞的自我更新的方法,包括诱导毛囊干细胞增殖,同时保持子细胞具有分化为毛囊上皮细胞的能力。
  • Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy
    申请人:Alcon, Inc.
    公开号:EP2281560A1
    公开(公告)日:2011-02-09
    The use of inhibitors of GSK-3 useful for treating, preventing or inhibiting glaucoma, including treating glaucomatous optic neuropathy, is disclosed.
    本研究公开了用于治疗、预防或抑制青光眼(包括治疗青光眼性视神经病变)的 GSK-3 抑制剂的用途。
  • Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III
    申请人:Frequency Therapeutics, Inc.
    公开号:US10016507B2
    公开(公告)日:2018-07-10
    The present invention relates to compositions and methods of inducing the self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.
    本发明涉及诱导干/祖支持细胞自我更新的组合物和方法,包括诱导干/祖细胞增殖,同时保持子细胞分化成毛细胞的能力。
  • Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
    申请人:Frequency Therapeutics, Inc.
    公开号:US10201540B2
    公开(公告)日:2019-02-12
    The present invention relates to compositions and methods of inducing the self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair cells.
    本发明涉及诱导干/祖支持细胞自我更新的组合物和方法,包括诱导干/祖细胞增殖,同时保持子细胞分化成毛细胞的能力。
查看更多

同类化合物

顺式-2-BOC-八氢-吡咯并[3,4-D]氮杂庚烷 羟甲磺酸二甲磺酸 环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 四氢-1H-吡咯并[1,2-a]氮杂卓-3,9(2H,9aH)-二酮 吡咯并[1,2-a]氮杂-5-酮 吖庚英并[4,3-b]吲哚-1(2H)-酮,7-氟-3,4,5,6-四氢-6-甲基- 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-3,4-二氢-1H-吡啶并[4,3-B]吲哚-2(5H)-羧酸叔丁酯 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-碘-1,5,6,7-四氢-4H-吡咯并[3,2-C]吡啶-4-酮 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2-溴-5,6,7,8-四氢吡咯并[3,2-C]氮杂庚烷-4(1H)-酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1-苄基-八氢-吡咯并[3,4-b]吡啶 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 4-acetoxy-5,18-seco-20,21-dinor-ibogamine 3-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)-1-(1-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)ethylidene)-1H-isoindole (7S,10R)-2-methyl-5-[(Z)-2-(6-methylpyridin-3-yl)vinyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole 6-[(6-chloropyridin-3-yl)methyl]-9-fluoro-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole (2S,3S)-tartrate 6-[(Z)-2-(6-methylpyridin-3-yl)vinyl]-9-(trifluoromethoxy)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 6-[2-(6-methylpiperidin-3-yl)ethyl]-9-(trifluoromethoxy)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 9-methyl-6-[(Z)-2-pyridin-3-ylvinyl]-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 8-methyl-5,15-dihydro-6H-naphtho[2',3':1,2]indolizino[8,7-b]indole-9,14-dione 4-methyl-2-(trimethylsilyl)methylsulfanyl-1-azabicyclo[5.3.0]deca-2,7,9-triene 1-(N-Methyl-2-piperidyl)cyclohexan-carbonsaeureethylester 2-methyl-1,2,3,4,5,6,7,8-octahydro-2,5-indolodiazocine 9-methyl-6-[2-(2-methylphenyl)ethyl]-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 6-[(E)-2-pyridin-3-ylvinyl]-9-(trifluoromethoxy)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 6-[(Z)-2-(6-methylpyridin-3-yl)vinyl]-9-(methylsulfonyl)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 16α-Hydroxy-21-oxo-20ξ-dihydro-cleavamin 3-benzyl-9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-b]indole-8-carbaldehyde tert-butyl 3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxylate